Intellectual Property - December 15, 2014
Japan Grants Patent to Nordic Nanovector
The Japan Patent Office (JPO) has issued patent no. 5646652 entitled “NOVEL RADIOIMMUNOCONJUGATES AND USES THEREOF” to Nordic Nanovector. The issued claims cover Nordic Nanovector’s proprietary radioimmunotherapy (RIT) technology, including the company`s lead product candidate Betalutin™, a new targeted agent for the treatment of relapsed B-cell non-Hodgkin lymphoma (NHL).
Companies - December 12, 2014
Novo Nordisk Launches Community Health Collaborative
Novo Nordisk announced the launch of the Community Health Collaborative, a new initiative to support and expand healthy lifestyle programming in the Trenton, New Jersey area. The Community Health Collaborative provides grants to local 501c3 organizations pursuing innovative, community-based approaches to improving urban health and wellness. The program’s launch comes off the findings of an […]
Companies - December 12, 2014
AstraZeneca Closing Mass. Plant
AstraZeneca announced it will close a plant in Westborough, Massachusetts (U.S). in 2015, putting 180 employees out of work, and move the production from Massachusetts to plants in Sweden and Australia. The facility will lose some jobs in March and the rest throughout the year with the plant closing by year end, the Worcester Telegram reports. “We […]
Economic Analysis - December 11, 2014
Health Tech Growing in Finland
Health technology is now the largest and most significant high-tech segment in Finnish industry, representing 47 percent of Finland’s total high-tech product exports, according to FiHTA Healthtech Finland, an organization representing companies in the sector. The value of Finnish health technology product exports reached a new record of EUR 1.66 billion in 2013. Exports in the […]
Uncategorized - December 11, 2014
Study: Brain Sorts, Stores Memories
Researchers from the Norwegian University of Science and Technology’s Kavli Institute for Systems Neuroscience and Centre for Neural Computation have published new findings on how the brain is able to store many separate but similar events, in the Dec. 8 issue of PNAS. The brain has an enormous capacity to store memories and to keep […]
Clinical Trials - December 11, 2014
More Drugs in Swedish Pipeline
The report The Swedish Drug Development Pipeline in 2014 highlights the 98 companies actively developing novel treatments. The projects analyzed are future products for human use that reached clinical development, Phase I-III. Data and information in this report originate from a web-based survey and public information. Key findings in the 2014 report include: There are […]
